In five non-tumor samples from patients undergoing resection of colon cancer metastases and with minimal inflammatory changes in the liver, ACE2 was co-detected with the sinusoidal endothelial cell marker CLEC4M (a.k.a. DC-SIGNR) (Fig. 3a,c,e) and the bile canaliculi marker ABCC2 (a.k.a. MRP2) (Fig. 3b,d,f). Here, ABCC2 is linked to neoplasm.